KYNB

News Kyntra Bio targets Q4 2026 interim readout while extending cash runway into 2028

21d ago

SEC filing KYNB Delisted from Nasdaq Global Select Market; $50M Asset/Revenue Requirement Missed; 45-Day Plan Due May 18 2026; Potential Transfer to Nasdaq Capital Market

54d ago

News FibroGen GAAP EPS of -$3.51 beats by $0.37, revenue of $1.27M misses by $0.4M

78d ago

SEC filing KYNB Reports $1.3M Q4 Rev, $58.2M Net Loss, $109.4M Cash Runway to 2028, Launches Phase 3 Roxadustat Protocol Submission

78d ago

News FibroGen Q4 2025 Earnings Preview

79d ago

News Oil Declines As Iran Says 'Understanding' Reached In US Nuclear Negotiation

105d ago

News Bain Capital and Goldman Sachs Lead Financing for Truelink Capital's Acquisition of SouthernCarlson from Kyocera Corporation – Company Announcement - FT.com

112d ago

Scanner Unusual volume (3.1x average)

124d ago